Grünenthal GmbH
Grünenthal GmbH is a German pharmaceutical company headquartered in Aachen in Germany. It was founded in 1946 as Chemie Grünenthal and has been continuously family-owned. The company was the first to introduce penicillin into the German market in the postwar period, after the Allied Control Council lifted its ban.
Key facts
- Company.name
- Grünenthal GmbH
- Company.logo
- Grünenthal_logo_green.png
- Company.logo_alt
- Official logo of Grünenthal
- Company.image
- Campus Aachen Grunenthal.jpg
- Company.image_caption
- Headquarters of Grünenthal
- Company.former_name
- Chemie Grünenthal
- Company.type
- Private
- Company.industry
- Pharmaceutical
- Company.founded
- in Stolberg, North Rhine-Westphalia, Germany
- Company.hq_location
- Aachen, North Rhine-Westphalia, Germany
- Company.areas_served
- +100 countries worldwide
- Company.revenue
- €1.8 billion
Article
11 sectionsContents
- History
- Thalidomide (Contergan)
- Criminal trial
- Reparations
- Apology
- Leprosy treatment
- Versatis and Tapentadol cases
- Further drug development
- Social commitment
- References
- External links
Grünenthal GmbH is a German pharmaceutical company headquartered in Aachen in Germany. It was founded in 1946 as Chemie Grünenthal and has been continuously family-owned. The company was the first to introduce penicillin into the German market in the postwar period, after the Allied Control Council lifted its ban.
Grünenthal became infamous in the 1950s and 1960s for the development and sale of the teratogenic drug thalidomide, marketed as the sleeping pill Contergan and promoted as a morning sickness preventive. Thalidomide caused severe birth defects, miscarriages, and other severe health problems.